albuvirtide
Showing 1 - 5 of 5
HIV/AIDS Trial in Hefei (Albuvirtide)
Not yet recruiting
- HIV/AIDS
- Albuvirtide
-
Hefei, ChinaThe Second Hospital of Anhui Medical University
Jan 12, 2022
HIV/AIDS Trial in United States (Albuvirtide, 3BNC117 Antibody)
Unknown status
- HIV/AIDS
- Albuvirtide
- 3BNC117 Antibody
-
Canoga Park, California
- +6 more
Sep 28, 2021
HIV, AIDS Trial in China (albuvirtide, lopinavir-ritonavir, tenofovir)
Completed
- HIV Infections
- AIDS
- albuvirtide
- +3 more
-
Beijing, Beijing, China
- +11 more
Sep 28, 2021
HIV-1-infection Trial in United States (Albuvirtide, 3BNC117, Baseline ART)
Recruiting
- HIV-1-infection
- Albuvirtide
- +2 more
-
Palm Springs, California
- +6 more
Sep 28, 2021
HIV/AIDS Trial in Beijing (Albuvirtide, 3BNC117)
Not yet recruiting
- HIV/AIDS
- Albuvirtide
- 3BNC117
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 24, 2021